Solvent injection as a new approach for manufacturing lipid nanoparticles -: evaluation of the method and process parameters

被引:304
作者
Schubert, MA [1 ]
Müller-Goymann, CC [1 ]
机构
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmazeut Technol, D-38106 Braunschweig, Germany
关键词
solid lipid; lipid nanoparticles; physicochemical characterization; solvent injection; crystallization;
D O I
10.1016/S0939-6411(02)00130-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lipid nanoparticles (LNP) can be prepared by rapidly injecting a solution of solid lipids in water-miscible solvents or a water-miscible solvent mixture into water. The aim of the present study was to evaluate the potential of this method for the preparation of LNP and the physicochemical characterization of the particles produced by this method. The results show that solvent injection is a potent and versatile approach for LNP preparation. Acetone, ethanol, isopropanol and methanol are suitable solvents in contrast to ethylacetate with which no LNP could be prepared. The obtained particle sizes (z-average) were between 80 and 300 nm depending on the preparation conditions. Up to 96.5% of the employed lipid was directly transformed into LNP. The LNP formation process seems to be diffusion controlled. Physicochemical characterization of the particles by differential scanning calorimetry (DSC), transmission electron microscopy and X-ray diffraction analysis reveals a distinct decrease in crystallinity of the colloidal lipid in comparison to the bulk lipid. Furthermore, DSC analysis of LNP hints at a delayed recrystallization of the colloidal lipid and the presence of two modifications. Therefore, a certain physical instability of the LNP has to be considered. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 16 条
[1]   Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters [J].
Almeida, AJ ;
Runge, S ;
Muller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 149 (02) :255-265
[2]  
[Anonymous], [No title captured], Patent No. 5118528
[3]   SINGLE BILAYER LIPOSOMES PREPARED WITHOUT SONICATION [J].
BATZRI, S ;
KORN, ED .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 298 (04) :1015-1019
[4]   Incorporation of the model drug ubidecarenone into solid lipid nanoparticles [J].
Bunjes, H ;
Drechsler, M ;
Koch, MHJ ;
Westesen, K .
PHARMACEUTICAL RESEARCH, 2001, 18 (03) :287-293
[5]  
DAVIES JT, 1961, INTERFACIAL PHENOMEN, P319
[6]  
Gasco M. R, 1993, US Patent, Patent No. [5 250 236, 5250236]
[7]  
Hagemann J., 1988, CRYSTALLIZATION POLY, P29
[8]   CLASSIFICATION OF GLYCERIDE CRYSTAL FORMS [J].
LARSSON, K .
ACTA CHEMICA SCANDINAVICA, 1966, 20 (08) :2255-&
[9]   Solid lipid nanoparticles (SLN) for controlled drug delivery -: a review of the state of the art [J].
Müller, RH ;
Mäder, K ;
Gohla, S .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :161-177
[10]  
Muller RH, 1996, European Patent No, Patent No. [EP0605497, 0605497]